Subsequent Events (Details) - Subsequent Event - Kuros Biosciences AG, Kuros US LLC and Kuros Royalty Fund (US) LLC - Royalty Purchase Agreement $ in Millions |
Jul. 14, 2021
USD ($)
|
|---|---|
| Subsequent Event [Line Items] | |
| Royalties entity has right to receive (as a percent) | 100.00% |
| Pre-commercial milestone payments | $ 25.0 |
| Upfront payment | $ 7.0 |
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Definition Maximum eligible milestone payments receivable upon achievement of development, pre-commercial milestones. No definition available.
|
| X | ||||||||||
- Definition Royalties entity has the right to receive as a percentage. No definition available.
|
| X | ||||||||||
- Definition The cash outflow for upfront payment. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|